Physician

Brent Hammal Limbaugh, M.D., PH.D.

According to 2025 Medicare claims, Brent Limbaugh, M.D., PH.D. (NPI: 1285727404) practices hematology/oncology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES PC (NPI: 1255163614; TIN: 581481590) and primary practice location at 29841-3862.

Limbaugh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 884 traditional Medicare patients, billed 177,015 HCPCS/CPT codes, and received $2,382,778 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,417 prescription claims across 459 beneficiaries totaling $6,108,287 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 60 claims. Open Payments data shows 215 records totaling $4,184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,517,288 to $6,108,287. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,831 to $1,520.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	812	258,650	$2,376,712
2016	866	219,087	$2,481,660
2017	859	283,548	$2,972,753
2018	1,050	307,422	$3,408,503
2019	1,058	366,575	$4,710,670
2020	1,070	283,856	$3,533,874
2021	938	224,549	$2,660,239
2022	1,013	240,945	$3,002,730
2023	967	224,568	$2,830,470
2024	884	177,015	$2,382,778

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	307	2,287	$2,517,288
2016	289	2,100	$3,351,296
2017	326	2,272	$3,844,240
2018	429	2,579	$4,255,513
2019	457	2,467	$4,227,539
2020	395	2,146	$4,682,002
2021	421	2,239	$3,850,374
2022	391	2,136	$4,627,195
2023	454	2,080	$5,145,309
2024	459	2,417	$6,108,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$3,967
2016	N/R	81	$12,618
2017	N/R	117	$13,838
2018	N/R	129	$7,312
2019	N/R	178	$10,108
2020	N/R	82	$3,899
2021	N/R	72	$2,931
2022	N/R	83	$3,412
2023	N/R	72	$3,746
2024	N/R	60	$3,130

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	384	806	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	346	474	$62
80053	Blood test, comprehensive group of blood chemicals	687	1,608	$10
36415	Insertion of needle into vein for collection of blood sample	766	2,050	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	743	1,970	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	52	1,407	$646,090
Revlimid	Lenalidomide	36	994	$562,648
Doptelet	Avatrombopag Maleate	22	635	$410,942
Orserdu	Elacestrant Hcl	17	510	$390,519
Nubeqa	Darolutamide	29	870	$382,862

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4409	Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$1,461
A4432	Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each	N	N/R	12	$916
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$388
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	12	$212
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	12	$153

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	215	$4,184	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brent Hammal Limbaugh, M.D., PH.D.?

Tedicare shows public-source Medicare data for Brent Hammal Limbaugh, M.D., PH.D. (NPI 1285727404), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brent Hammal Limbaugh, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brent Hammal Limbaugh, M.D., PH.D.?

Brent Hammal Limbaugh, M.D., PH.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES PC (billing NPI 1255163614) in the available physician profile data.

Does Brent Hammal Limbaugh, M.D., PH.D. have Open Payments data?

Brent Hammal Limbaugh, M.D., PH.D. has 215 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.